BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Regains Compliance With NASDAQ $1.00

[Biostar Pharmaceuticals, Inc. Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule BSPM XIANYANG, China, Nov. 13, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. ( Ronghua Wang, Biostar's Chairman, commenting on the announcement, stated: "We strongly believe that regaining compliance with NASDAQ's continued listing requirements is an important achievement for the Company. Having resolved this issue, we can continue focusing on]

By | 2016-03-03T10:41:15+00:00 November 14th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

NTES [NetEase] 6-K: Contact for Media and Investors: Cassia Curran NetEase,Inc.

[Contact for Media and Investors: Cassia Curran NetEase,Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports Third Quarter 2013 Unaudited Financial Results (Beijing November13, 2013) NetEase,Inc. (NASDAQ: NTES), one of Chinas leading Internet and online game services providers, today announced its unaudited financial results for the third quarter ended]

By | 2016-01-11T11:13:17+00:00 November 14th, 2013|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments
Read More

MY [CHINA MING YANG WIND POWER] 6-K: (Original Filing)

[China Ming Yang Wind Power Group Limited Company (the “ Notice of Annual General Meeting of the Company AGM Notice is hereby given that an Annual General Meeting of the Company (the “ 1 As an ordinary resolution that the Company’s audited consolidated financial statements for the fiscal year ended December 31, 2012 be approved and adopted; 2 As an] [China Ming Yang Wind Power Group Limited Company (the “ FORM OF PROXY FOR SHAREHOLDERS I/We Please Print Name(s) of Please Print Address(es) being (a) shareholder(s) of the Company with shares respectively hereby appoint of or failing him/her of Chairman AGM or failing him/her the duly appointed chairman of the AGM (the “ Resolution For Against Abstain 1. As an]

By | 2016-02-29T22:21:12+00:00 November 14th, 2013|Categories: Chinese Stocks, MY, SEC Original|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093013.htm]

By | 2016-03-03T16:35:28+00:00 November 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Read More

MY [CHINA MING YANG WIND POWER] 6-K: China Ming Yang Wind Power Group Limited Company

[China Ming Yang Wind Power Group Limited Company (the “ Notice of Annual General Meeting of the Company AGM Notice is hereby given that an Annual General Meeting of the Company (the “ 1 As an ordinary resolution that the Company’s audited consolidated financial statements for the fiscal year ended December 31, 2012 be approved and adopted; 2 As an] [China Ming Yang Wind Power Group Limited Company (the “ FORM OF PROXY FOR SHAREHOLDERS I/We Please Print Name(s) of Please Print Address(es) being (a) shareholder(s) of the Company with shares respectively hereby appoint of or failing him/her of Chairman AGM or failing him/her the duly appointed chairman of the AGM (the “ Resolution For Against Abstain 1. As an]

By | 2016-02-29T22:21:55+00:00 November 14th, 2013|Categories: Chinese Stocks, MY, Webplus ver|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2013

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093013.htm]

By | 2016-03-03T16:36:22+00:00 November 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Bing Mei Chief Financial Officer]

By | 2016-03-01T03:53:33+00:00 November 14th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Bing Mei Chief Financial Officer]

By | 2016-03-01T03:54:36+00:00 November 14th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x September 30, 2013

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 ex32-2.htm 5 EX-32.2]

By | 2016-02-07T15:05:26+00:00 November 14th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

HPJ [Highpower International] 10-Q: (Original Filing)

[] [Maximum Amount Comprehensive Credit Line Contract NO. SX161213000233 Borrower: Address: Building A1, 68 Xinxia Street, Pinghu, Longgang, Shenzhen. Creditor: Address:4011, Shennan Road, Futian District, Shenzhen. According to relevant laws and regulations of China, this contract was agreed to by the two parties, and both parties agree to comply with all terms of the contract. Clause 1 Clause 2 Content of] [Working Capital Loan Contract REF: JK161213000014 Party A: Address: Building A1, 68 Xinxia Street, Pinghu, Longgang, Shenzhen. Party B: Address: 4011, Shennan Road, Futian District, Shenzhen. According to relevant laws and regulations of China, this contract was agreed by two parties, and both of them will be in accordance with the terms of the contract. Clause 1 Content of the] [Number :40000928-2013 (Henggang) No. 0040 Working capital loan contract The lender (the loan) Person in charge: Duoping Yang Contact: Xiaomin Hong Residence (address): City Center Garden Street shops 101, 201, Henggang Street, Longgang District, Shenzhen Zip Code: 518115 Tel 0755 -28433033 Fax 0755 -28858699 E-mail: / Borrower Legal representative: George Pan Contact: Eric Li Residence (address): Building A2, Luoshan Industrial,] [Basic Credit Line Contract Reference: Xing Yin Shen Longgang credit zi (2013) No. 0430 Creditor: Industrial Bank Co., Ltd., Shenzhen Longgang Branch Address: Parkland, Longxiang Road, Longgang town, Shenzhen Legal Representative / CEO: Jinkui Li Contact: Address: Postal Code: Fax : Tel: 0755-33837817 Fax: Debtor: Springpower Technology (Shenzhen) Co., Ltd. Address: Building A, Chaoshun Industrial Zone, Renmin Street, Danhu, Guanlan] [Working capital loan contract Reference: Xing Yin Shen Longgang loan zi (2013) No. 0430 Lender: Industrial Bank Co., Ltd., Shenzhen Longgang Branch Address: Parkland, Longxiang Road, Longgang Town, Shenzhen Legal Representative / CEO: Jinkui Li Contact: Jinlong Huang Address: Postal Code: Fax : Tel: 0755-33837817 Fax: Borrower: Springpower Technology (Shenzhen) Co., Ltd. Address: Building A, Chaoshun Industrial Zone, Renmin Street,] [REF: Comprehensive Credit Line Contract Contents Chapter one Definitions and interpretation Chapter two The maximum credit limits and Specific line of credit Chapter three The period of credit Chapter four Usage of the Maximum Credit Limits and Specific Line of Credit Chapter five The Fees Chapter six Adjustment of the Maximum Credit Limits and Specific Line of Credit Chapter seven] [REF: ZH78191309001-1JK Working Capital Loan Contract CHINA EVERBRIGHT BANK Contents Article I General Principal Article II Purpose of the Loan Article III Currency, Amount, Term and Disbursement of the Loan Article IV Interest of the Loan and Calculation Method Article V Release and Use of the Loan Article VI Repayment of the Loan Article VII Guarantee Article VIII Assumption of] [Maximum Amount Comprehensive Credit Line Contract NO. SX161213000377 Fiduciary: Address: Building A, Chaoshun Industrial Zone, Renmin Street, Danhu, Guanlan Road, Baoan, Shenzhen Creditor: Address: 4011, Shennan Road, Futian District, Shenzhen. According to relevant laws and regulations of China, this contract was agreed by two parties, and both parties agree to comply with all terms of the contract. Clause 1 Clause] [Working Capital Loan Contract REF: JK161213000016 Party A: Address: Building A, Chaoshun Industrial Zone, Renmin Street, Danhu, Guanlan Road, Baoan, Shenzhen Party B: Address: 4011, Shennan Road, Futian District, Shenzhen. According to relevant laws and regulations of China, this contract was agreed by two parties, and both of them will be in accordance with the terms of the contract. Clause] [Private & Confidential Our Reference: CMD-OU-2013-2647HA-FL 29 July 2013 Hong Kong Highpower Technology Company Limited Unit 12 15/F Technology Park 18 on Lai Street Shek Mun Shatin NT Dear Sirs, Additional Banking Facility Re : Further to our facility letter dated 14 March 2013 under ref. CMD-OU-2013-0708HA-FL (the “Facility Letter”), we are pleased to advise you that Industrial and Commercial] [THE SHANGHAI COMMERCIAL & SAVINGS BANK, LTD. HONG KONG BRANCH (INCORPORATED IN TAIWAN WITH LIMITED LIABILITY) Private and Confidential Our Reference: 6400102110139 26th August 2013 Hong Kong Highpower Technology Company Limited Re: Banking Facility up to a limit of USD3,000,000 Borrower: Hong Kong Highpower Technology Company Limited Facility Letter Appendix We refer to the banking facility currently made available to] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Dang Yu Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Highpower International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Henry Sun, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Highpower International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dang Yu Pan Chairman of the Board and Chief Executive Officer November 12, 2013 Henry Sun Chief Financial Officer (Principal Financial and Accounting Officer) November 12, 2013]

By | 2016-03-14T08:51:00+00:00 November 14th, 2013|Categories: Chinese Stocks, HPJ, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar